TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASES

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20190314328A1
SERIAL NO

16453934

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Mixtures of vitamin E and polyunsaturated fatty acids (PUFAs) are provided as agents for the prevention, control and/or treatment of conditions associated with excessive fat accumulation in the liver which is not caused by alcohol abuse, including control and/or treatment of non-alcoholic steatosis in the liver—known as non-alcoholic fatty liver disease (NAFLD)—and/or non-alcoholic steatohepatitis (NASH) in a subject in need thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DSM IP ASSETS BVHOLLAND SITTARD

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
PETER, Szabolcs Kaiseraugst, CH 5 0
SCHWAGER, Joseph Kaiseraugst, CH 29 74

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation